Alkem Laboratories Ltd
NSE: ALKEM BSE: 539523
₹5402.50
(-7.97%)
Sat, 14 Feb 2026, 04:59 pm
Market Cap645.84B
PE Ratio27.27
Dividend0.83
Health Technology
Pharmaceuticals: Major
24.5KAlkem Laboratories Income Statement
| Particulars | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 16.65B | 19.73B | 24.44B | 30.67B | 37.01B | 48.57B | 56.38B | 63.59B | 73.07B | 82.75B | 88.23B | 106.17B | 115.83B | 125.67B | 129.30B |
| Gross profit | 5.84B | 7.67B | 9.12B | 11.06B | 13.22B | 19.12B | 23.08B | 24.83B | 22.89B | 26.88B | 29.73B | 35.95B | 37.59B | 46.39B | 48.38B |
| Operating expenses (excl. COGS) | -3.41B | -4.57B | -6.27B | -7.80B | -9.76B | -11.96B | -14.41B | -16.21B | -13.62B | -15.03B | -13.03B | -18.10B | -23.93B | -26.87B | -26.53B |
| Selling/general/admin expenses, total | -3.30B | -4.47B | -6.08B | -7.64B | -9.50B | -11.64B | -14.10B | -15.85B | -13.38B | -14.58B | -12.59B | -17.64B | -23.24B | -26.35B | -26.25B |
| Research & development | -485.20M | -755.20M | -1.08B | -1.57B | -1.70B | -2.17B | -3.20B | -3.65B | -4.62B | -4.73B | -5.32B | -5.67B | -5.39B | -5.23B | -5.62B |
| Selling/general/admin expenses, other | -2.82B | -3.72B | -5.00B | -6.07B | -7.81B | -9.48B | -10.89B | -12.21B | -8.75B | -9.85B | -7.27B | -11.97B | -17.84B | -21.12B | -20.63B |
| Other operating expenses, total | -107.20M | -99.30M | -186.40M | -160.30M | -252.70M | -317.10M | -317.10M | -354.60M | -241.20M | -453.60M | -444.90M | -462.80M | -687.30M | -523.40M | -279.30M |
| Operating income | 2.43B | 3.10B | 2.85B | 3.26B | 3.47B | 7.74B | 8.67B | 8.63B | 9.28B | 11.86B | 16.70B | 17.84B | 13.67B | 19.51B | 21.85B |
| Non-operating income, total | 881.40M | 1.23B | 1.16B | 1.04B | 1.70B | 1.55B | 976.70M | 634.10M | 269.90M | 742.60M | 1.72B | 599.10M | -620.60M | 718.30M | 3.42B |
| Interest expense, net of interest capitalized | -412.30M | -581.00M | -882.30M | -930.80M | -811.10M | -712.40M | -405.20M | -501.10M | -476.20M | -650.60M | -589.20M | -424.20M | -1.07B | -970.80M | -1.05B |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 1.29B | 1.81B | 2.05B | 1.90B | 2.51B | 1.51B | 1.33B | 1.40B | 718.30M | 1.60B | 2.05B | 943.30M | 1.20B | 2.17B | 4.03B |
| Non-operating interest income | 979.00M | 1.21B | 1.60B | 1.49B | 1.29B | 1.27B | 1.03B | 787.20M | 412.80M | 631.20M | 901.20M | 1.23B | 1.71B | 2.76B | 3.59B |
| Miscellaneous non-operating expense | 314.70M | 609.70M | 447.20M | 413.20M | 1.22B | 235.50M | 308.20M | 611.10M | 305.50M | 966.90M | 1.14B | -283.50M | -511.40M | -587.90M | 441.20M |
| Unusual income/expense | — | — | — | 72.70M | — | 752.90M | 47.00M | -263.10M | 27.80M | -204.90M | 266.90M | 80.00M | -747.00M | -480.70M | 436.50M |
| Pretax income | 3.31B | 4.33B | 4.02B | 4.30B | 5.17B | 9.28B | 9.65B | 9.26B | 9.55B | 12.60B | 18.42B | 18.44B | 13.05B | 20.23B | 25.27B |
| Taxes | -355.70M | -275.20M | -179.70M | 53.60M | -541.80M | -1.76B | -599.60M | -2.88B | -1.81B | -1.10B | -2.24B | -1.64B | -2.98B | -2.12B | -3.11B |
| Non-controlling/minority interest | -1.90M | 7.00M | 1.90M | 0 | 0 | -106.40M | -126.40M | -74.80M | -131.30M | -222.40M | -327.50M | -347.00M | -226.40M | -156.90M | -499.00M |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 2.96B | 4.07B | 3.84B | 4.35B | 4.63B | 7.42B | 8.92B | 6.31B | 7.61B | 11.27B | 15.85B | 16.46B | 9.84B | 17.96B | 21.65B |
| Net income | 2.96B | 4.07B | 3.84B | 4.35B | 4.63B | 7.42B | 8.92B | 6.31B | 7.61B | 11.27B | 15.85B | 16.46B | 9.84B | 17.96B | 21.65B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 2.96B | 4.07B | 3.84B | 4.35B | 4.63B | 7.42B | 8.92B | 6.31B | 7.61B | 11.27B | 15.85B | 16.46B | 9.84B | 17.96B | 21.65B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 2.71B | 3.39B | 3.25B | 3.78B | 4.17B | 8.10B | 9.68B | 10.06B | 11.21B | 14.38B | 19.44B | 20.88B | 16.77B | 22.51B | 25.42B |
| EBIT | 2.43B | 3.10B | 2.85B | 3.26B | 3.47B | 7.16B | 8.67B | 8.63B | 9.28B | 11.86B | 16.70B | 17.84B | 13.67B | 19.51B | 21.85B |
| Total operating expenses | -14.22B | -16.63B | -21.59B | -27.41B | -33.55B | -40.84B | -47.71B | -54.96B | -63.79B | -70.90B | -71.53B | -88.33B | -102.16B | -106.16B | -107.45B |
| Prepaid expenses | 26.90M | 171.10M | 177.80M | 159.30M | 147.80M | 158.00M | 195.60M | 205.60M | 321.20M | 318.10M | 303.60M | 564.40M | 443.90M | 499.10M | 595.30M |
| Deferred income, current | — | — | 2.70M | 73.90M | 96.00M | 220.70M | 327.10M | 343.50M | 302.20M | 368.90M | 395.60M | 728.70M | 739.70M | 1.12B | 2.20B |
| Capital and operating lease obligations | 6.70M | 1.90M | 123.30M | 77.80M | 51.40M | 0 | 63.30M | 63.30M | 63.20M | 697.10M | 697.10M | 664.70M | 703.30M | 1.89B | 2.67B |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 228.10M | 336.60M | 481.30M | 441.90M | 945.60M | 10.10M | 4.70M | 16.70M | 1.80B | 1.67B | 1.74B | 2.19B | 1.96B | 2.56B | 2.33B |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | 0 | 0 |
| Minority interest | 18.20M | 1.90M | 0 | 0 | 856.50M | 950.20M | 1.15B | 1.22B | 1.33B | 1.48B | 1.81B | 2.09B | 3.90B | 4.02B | 4.49B |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | -209.10M | -517.10M | -318.60M | -566.70M | -1.84B | -863.40M | -2.18B | -2.19B | -4.40B | -3.35B | -4.22B | -5.30B | -5.38B | -5.05B |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800